Login to Your Account



Good 'Forma': New Deal Adds Celgene to Partnership Roster

By Jennifer Boggs
Managing Editor

Tuesday, April 30, 2013
Drug discovery firm Forma Therapeutics Holdings LLC racked up another collaboration – its biggest so far – inking Celgene Corp. to a potential multicandidate deal targeting protein homeostasis, a new area of biology linked to oncology, neurodegenerative disorders and other diseases.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription